Last updated: July 9, 2025
Sponsor: Cantonal Hospital of St. Gallen
Overall Status: Completed
Phase
N/A
Condition
Rectal Cancer
Colon Cancer
Surgery
Treatment
Transanal total mesorectal excision
Abdominal total mesorectal excision
Clinical Study ID
NCT06505863
taTME QoL
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- elective total mesorectal excision followed by reconstruction with anastomosis forprimary rectal cancer
Exclusion
Exclusion Criteria:
diagnoses other than rectal cancer
recurrent rectal cancer
partial mesorectal excision
discontinuity resection (no anastomosis)
incomplete TNM staging information
metastatic cancer
30-day mortality
lack of quality of life data
patient decline
age under 18 years
Study Design
Total Participants: 249
Treatment Group(s): 2
Primary Treatment: Transanal total mesorectal excision
Phase:
Study Start date:
August 01, 2024
Estimated Completion Date:
July 01, 2025
Study Description
Connect with a study center
Cantonal Hospital of St.Gallen
Saint-Gall, 9000
SwitzerlandSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.